A citation-based method for searching scientific literature

John Dupré, Margaret T Behme, Thomas J McDonald. J Clin Endocrinol Metab 2004
Times Cited: 92



Michael A Nauck, Markus M Heimesaat, Kai Behle, Jens J Holst, Markus S Nauck, Robert Ritzel, Michael Hüfner, Wolff H Schmiegel. J Clin Endocrinol Metab 2002
Times Cited: 401




List of shared articles



Times cited

Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes.
Laura Marroquí, Paloma Alonso-Magdalena, Beatriz Merino, Esther Fuentes, Angel Nadal, Ivan Quesada. Nutr Res Rev 2014
26


Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists.
Urd Kielgast, Jens J Holst, Sten Madsbad. Curr Diabetes Rev 2009
37

Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide.
Claudio González, Valeria Beruto, Guillermo Keller, Silvina Santoro, Guillermo Di Girolamo. Expert Opin Investig Drugs 2006
20


GLP-1: physiological effects and potential therapeutic applications.
Kasper Aaboe, Thure Krarup, Sten Madsbad, Jens Juul Holst. Diabetes Obes Metab 2008
57


GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
24

The alpha-cell as target for type 2 diabetes therapy.
Mikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, Filip K Knop. Rev Diabet Stud 2011
30

Is exenatide a useful addition to diabetes therapy?
Nasser E Mikhail. Endocr Pract 2006
4

Alpha lipoic acid attenuates high-fructose-induced pancreatic toxicity.
Senay Topsakal, Ozlem Ozmen, Fatma Nihan Cankara, Sukriye Yesilot, Dilek Bayram, Nilüfer Genç Özdamar, Sümeyra Kayan. Pancreatology 2016
4


Incretins.
Tongzhi Wu, Christopher K Rayner, Michael Horowitz. Handb Exp Pharmacol 2016
34